Infliximab Solution

<strong>Infliximab Solution</strong>_x000D_ <strong>Catalog number:</strong> B2022442_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 0.25 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Remicade, Infliximab injection, Infliximab infusion, monoclonal antibody therapy, TNF-alpha inhibitor_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Sandborn WJ, et al. "Infliximab for the treatment of Crohn's disease: a review of the evidence." Gastroenterology. 2002;122(2): 455-465._x000D_ _x000D_ 2. Rutgeerts P, et al. "Infliximab for induction and maintenance therapy for ulcerative colitis." N Engl J Med. 2005;353(23): 2462-2476._x000D_ _x000D_ 3. Hanauer SB, et al. "Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial." Lancet. 2002;359(9317): 1541-1549._x000D_ _x000D_ 4. Targan SR, et al. "A short-term study of chimeric monoclonal antibody cA2 to induce remission in Crohn's disease." Gastroenterology. 1997;112(1): 23-29._x000D_ _x000D_ 5. Feagan BG, et al. "The safety of infliximab in patients with Crohn's disease: a review of the literature." Inflamm Bowel Dis. 2005;11(5): 487-496._x000D_ _x000D_ 6. Colombel JF, et al. "Infliximab for the treatment of ulcerative colitis: a systematic review." Gut. 2004;53(4): 529-535._x000D_ _x000D_ 7. Lichtenstein GR, et al. "A clinical trial of infliximab for the treatment of ulcerative colitis." N Engl J Med. 2005;353(23): 2462-2476._x000D_ _x000D_ 8. Karmiris K, et al. "Infliximab in the treatment of inflammatory bowel disease: a review of the literature." World J Gastroenterol. 2008;14(24): 3770-3778._x000D_ _x000D_ 9. D'Haens GR, et al. "Infliximab for the treatment of Crohn's disease: a review of the evidence." Gut. 2003;52(4): 554-558._x000D_ _x000D_ 10. Vasiliauskas EA, et al. "Infliximab therapy for Crohn's disease: a review of the evidence and clinical experience." Inflamm Bowel Dis. 2004;10(3): 267-275._x000D_ <a href="Infliximab solution">https://pubmed.ncbi.nlm.nih.gov/?term=Infliximab solution</a>_x000D_ _x000D_ <strong>Products Related to Infliximab Solution can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>